Cargando…
The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism
A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/ https://www.ncbi.nlm.nih.gov/pubmed/25949409 http://dx.doi.org/10.1093/ndtplus/sfp120 |
_version_ | 1782369894461865984 |
---|---|
author | Khalpey, Zain Nehs, Matthew A. ElBardissi, Andrew W. Semel, Marcus Tullius, Stefan G. |
author_facet | Khalpey, Zain Nehs, Matthew A. ElBardissi, Andrew W. Semel, Marcus Tullius, Stefan G. |
author_sort | Khalpey, Zain |
collection | PubMed |
description | A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyroid levels had dropped significantly following treatment initiation. However, within 7 months, the patient experienced extensive necrotic bilateral medial thigh ulcers. These were biopsied and found to be a result of calciphylaxis. The patient ultimately required an urgent subtotal parathyroidectomy and recovered well with completely healed ulcers. |
format | Online Article Text |
id | pubmed-4421548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44215482015-05-06 The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism Khalpey, Zain Nehs, Matthew A. ElBardissi, Andrew W. Semel, Marcus Tullius, Stefan G. NDT Plus Case Report A 43-year-old African American with end-stage renal disease (ESRD) associated with membranous nephropathy and a previously failed renal transplant had received cinacalcet to treat his secondary hyperparathyroidism. Serum calcium and phosphorus levels remained within normal limits, and serum parathyroid levels had dropped significantly following treatment initiation. However, within 7 months, the patient experienced extensive necrotic bilateral medial thigh ulcers. These were biopsied and found to be a result of calciphylaxis. The patient ultimately required an urgent subtotal parathyroidectomy and recovered well with completely healed ulcers. Oxford University Press 2010-02 2009-09-08 /pmc/articles/PMC4421548/ /pubmed/25949409 http://dx.doi.org/10.1093/ndtplus/sfp120 Text en © The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Report Khalpey, Zain Nehs, Matthew A. ElBardissi, Andrew W. Semel, Marcus Tullius, Stefan G. The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title | The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title_full | The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title_fullStr | The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title_full_unstemmed | The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title_short | The importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
title_sort | importance of prevention of calciphylaxis in patients who are at risk and the potential fallibility of calcimimetics in the treatment of calciphylaxis for patients with secondary hyperparathyroidism |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421548/ https://www.ncbi.nlm.nih.gov/pubmed/25949409 http://dx.doi.org/10.1093/ndtplus/sfp120 |
work_keys_str_mv | AT khalpeyzain theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT nehsmatthewa theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT elbardissiandreww theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT semelmarcus theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT tulliusstefang theimportanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT khalpeyzain importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT nehsmatthewa importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT elbardissiandreww importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT semelmarcus importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism AT tulliusstefang importanceofpreventionofcalciphylaxisinpatientswhoareatriskandthepotentialfallibilityofcalcimimeticsinthetreatmentofcalciphylaxisforpatientswithsecondaryhyperparathyroidism |